It could indicate inadequate caloric intake, nutritional deficiencies, dehydration, or rarely, an underlying condition unmasked by the metabolic changes
Regulators said many of the companies were promoting compounded medications as if they were equivalent to approved brand-name drugs
One study reported that somatostatin does not suppress insulin secretion by acting on the central nervous system but acts peripherally on islet beta-cells
Wegovy (semaglutide) It was the first weekly injectable GLP-1 approved specifically for weight management in adults with a body mass index of 30 or higher, or 27 and above with at least one weight-related condition such as high blood pressure or type 2 diabetes
The increased dosage used in Wegovy has been carefully tested and shown to safely promote more substantial reductions in body weight, making it an ideal option for aesthetic patients looking for effective solutions to improve their appearance, confidence, and overall health
This constant bile exposure can increase intestinal sensitivity to GLP-1's effects on motility and secretion, making nausea, bloating, and diarrhea more likely